Top Infectious Disease Diagnostics Companies

Infectious disease diagnostics providers should focus on increasing the efficacy of their tests and reduce their result times by investing in R&D. Leveraging advanced technologies such as AI and molecular diagnostics is also a prominent opportunity for companies as per this global infectious disease diagnostics market analysis.

Development of rapid diagnostic test kits is the prime focus of new companies. Here’s a startup that is pioneering novel tests and diagnostics for a variety of infectious diseases.

• Sherlock Biosciences: This Boston, United States-based biotech startup is pioneering CRISPR-based diagnostic platforms. The company developed the SHERLOCK and INSPECTR technologies for rapid, accurate, and low-cost detection of infectious diseases like COVID-19 and influenza. Their focus on instrument-free and point-of-care diagnostics makes them ideal for decentralized testing. Backed by high-profile investors and academic institutions, the 2019-founded company’s innovations aim to revolutionize infectious disease testing with fast and accessible solutions.

Top Player’s Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)

• Abbott (US)

• bioMerieux (France)

• Siemens Healthineers AG (Germany)

• Danaher (US)

• Thermo Fisher Scientific Inc. (US)

• Hologic, Inc. (US)

• Becton, Dickinson and Company (US)

• Revvity (US)

• Qiagen (Netherlands)

• Seegene Inc. (South Korea)

• QuidelOrtho Corporation (US)

• Grifols, S.A. (Spain)

• DiaSorin S.p.A. (Italy)

• Bio-Rad Laboratories, Inc. (US)

• Sysmex Corporation (Japan)

• OraSure Technologies (US)

• Co-Diagnostics, Inc. (US)

• Trinity Biotech (Ireland)

• Genetic Signatures Ltd. (Australia)